Rexulti 0.25 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3G5D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,593
Award facts
- Contract value 100% obligated
- $49,592.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for REXULTI 0.25 mg tablets (30-count) with a ceiling value of $49,592.87.
Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 6, 2026, and is priced on a firm fixed-price basis with no set-aside.
Quick answers
Who was awarded contract SPE2DR26F3G5D?
SPE2DR26F3G5D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 5, 2026.
How much is contract SPE2DR26F3G5D worth?
The government has obligated $49,593 on SPE2DR26F3G5D.
Is contract SPE2DR26F3G5D an order under another contract?
Yes. SPE2DR26F3G5D is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G5D competed?
The extent of competition for SPE2DR26F3G5D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award